15th Dec2015- Mumbai, India: Bharatbook.com announces a report on “Report on China Follicle-Stimulating Hormone (FSH) Market ”
The report also Explain the points of the FSH brought in a global sales value of over USD 1.2 billion in 2013 to which Gonal-f (FSHα) made by Merck Serono contributed USD 813 million with a market share of 63% while Puregon (FSHβ) of Merck contributed USD 481 million with a market share of 37%
According to WHO’s evaluation, one in seven couples suffer from fertility which influences about 10%-15% of the world population. According to a survey, the number of patients with fertility accounts for 10% of married people, being double of 4.8% in 1984. The incidence of fertility in young people has increased and it is 15%-20% among women of childbearing age. For patients with hypothalamic-pituitary dysfunction including polycystic ovary syndrome, FSH can promote follicular development while in the case of blocked fallopian tube, unexplained fertility and fertility caused by male factor, FSH can do so in the assistive technology used to conceive the child.
FSH brought in a global sales value of over USD 1.2 billion in 2013 to which Gonal-f (FSHα) made by Merck Serono contributed USD 813 million with a market share of 63% while Puregon (FSHβ) of Merck contributed USD 481 million with a market share of 37%. FSH develops fast after entering China, annual sales value rising from less than CNY 2 million in 2006 to CNY 215 million in 2014 and CAGR during this period reaching 84.2%. Merck Serono (rhFSHα), Livzon Pharmaceutical Group Co., Ltd (UFSH), IBSA (UFSH) and Organon (rhFSHβ) dominate the Chinese market, among which Livzon Pharmaceutical Group Co., Ltd has the largest market share of about 59% for sales value in 2014.https://www.bharatbook.com/healthcare-market-research-reports-683641/investigation-china-follicle-stimulating-hormone.html
As the number of patients suffering from infertility is huge in China, FSH has good market prospects.
Readers can get at least the following information from this report:
-market size of FSH in China
-competitive landscape of FSH in Chinese market
-price of FSH made by different enterprises in China
-market outlook of FSH in China
The author suggests the following groups of people purchase this report:
-manufacturers of endocrine regulator
-investors/ research institutions interested in Chinese medicine marketFor more information kindly visit: https://www.bharatbook.com/healthcare-market-research-reports-683641/investigation-china-follicle-stimulating-hormone.html
About Bharat Book Bureau :
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry analysis, country reports, business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
In case the reports don’t match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.
Contact us at :
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Follow us on Twitter: https://twitter.com/researchbook
Follow us on LinkedIn : http://www.linkedin.com/company/bharat-book-bureau
Our Blog : https://www.bharatbook.com/blog/
Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.